HIGHLIGHTS
- who: Ai-Yu Yang from the Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan have published the article: Comparative Assessment of the Long-Term Effectiveness and Safety of Dapagliflozin and Empagliflozin as Add-on Therapy to Hypoglycemic Drugs in Patients with Type 2 Diabetes, in the Journal: Journal of Diabetes Research of 23/05/2022
- what: The authors compared the long-term effectiveness and safety of SGLT2i (dapagliflozin versus empagliflozin) as add-on therapy to hypoglycemic agents in T2D patients.
- how: Patient data were collected using the electronic medical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.